PEP has dropped 5% on the week to $129.75, its weakest level in several months, as options sentiment shifts more cautious and the Street sits firmly on the sidelines ahead of an October earnings test.
The clearest signal of rising unease is in options. The put/call ratio climbed to 0.52, nearly two standard deviations above its 20-day average of 0.48 — the most defensively positioned reading in recent months. That z-score of 1.94 is not yet extreme, but the direction of travel is clear: protection demand has picked up as the stock extended its decline. The borrow market tells a far less dramatic story. Availability is essentially unconstrained, with billions of shares available to lend and cost-to-borrow sitting at just 0.46% — both figures consistent with a large-cap stock that short sellers have no particular urgency to attack. Short interest has actually eased sharply, falling 27% over the past month to 1.6% of the free float. That is a low absolute level, and the direction suggests recent sellers have been longs exiting, not shorts building. The ORTEX short score of 31.2 reinforces that: low and stable, with almost no movement across the past two weeks.
The Street's posture is cautious but not hostile. The consensus is a hold, with the mean price target around $155 — implying roughly 19% upside from current levels, which sounds generous until you consider how far targets have already been cut. Following Q2 results in early July, analysts at Morgan Stanley, Wells Fargo, Jefferies, TD Cowen, and Citigroup all trimmed their targets, with Citi also downgrading to Neutral from Buy. Barclays subsequently nudged its Equal-Weight target slightly higher to $142 after the dust settled, but the broader analyst direction has been one of reset, not recovery. The bull case centres on international growth in Asia and EMEA, affordability strategies, and ongoing productivity measures. Bears point to declining domestic consumption, tariff-driven cost pressure on gross margins, and the risk that pricing power fades faster than the market currently prices in. Valuation multiples have compressed with the share price: the P/E has fallen roughly 1.1 turns over the past month to around 15x, and EV/EBITDA is down 0.08 turns to 11.4x. Neither level looks cheap enough to act as a floor on its own.
The institutional picture is broadly stable. BlackRock holds an 8.7% stake, Vanguard entities collectively account for a further 10%, and State Street sits at 4.4%. Most of the top holders were adding modestly at the last reporting date, though these figures reflect positions from as recently as August 31. Charles Schwab Investment Management added nearly 5.9 million shares in the period, the largest move among the top holders. On the activist register, The Vanguard Group filed a 13G/A in March 2026 showing a reduction from 10% to zero — though the disclosure caveat applies: stakes are event-driven around the 5% threshold, and actual current positions may differ. There is no 13D activist on the register. Insider activity is thin and uninformative: the only price-bearing transaction in the past 90 days was a $405,000 open-market sale by the General Counsel in late July, a modest, non-plan disposal.
PEP's recent earnings history shows the stock can move sharply in either direction at results. The July 2026 Q2 print produced a one-day gain of around 3.6%, while an earlier July event saw a 3.6% drop on the day and a further 2.2% drift over five sessions. The October 8 Q3 print is the next focus. That report will test whether the sequential improvement seen in Q2 — which drove shares higher on the day — carries into the third quarter, or whether the margin pressure flagged by the bear case is beginning to show up in the numbers. With the stock now more than 7% lower than a month ago and analyst targets clustered well above the current price, the October 8 release is where the gap between Street expectations and price action gets its first real reckoning.
See the live data behind this article on ORTEX.
Open PEP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
